Earnings Call · Q2 FY2024·2024-08-05

Q2 24EPS +100.00%*·Rev n/aQ1 24EPS -17.50%·Rev n/aQ4 23EPS -42.71%·Rev n/aQ3 23EPS +98.13%·Rev n/a⚠ consensus missing

MEDIFAST INC MED

Steven Zenker — Investor Relations or Communications (inferred from hosting the call and introducing executives)

Dan Chard — Chairman and Chief Executive Officer

Jim Maloney — Chief Financial Officer

−2.8%1d on move date+0.1% vs SPY3d−7.3%5d−9.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MED calls or request research access.

More MED calls Browse calls Request research access